Gloria Ivy Mensah

Dr. Gloria Ivy Mensah

Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2010 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
PDF file
KAK. K. Addo
K. K. Addo
GMGloria Ivy Mensah
Gloria Ivy Mensah
KAK. G. Aning
K. G. Aning
NNN. Nartey
N. Nartey
GNG. K. Nipah
G. K. Nipah
HSH. L. Smits
H. L. Smits

11 March 2019 in Veterinary Medicine and Science
Verified
Journal Article
Open access
PDF file
SJSherry Ama Mawuko Johnson
Sherry Ama Mawuko Johnson
JKJohn B. Kaneene
John B. Kaneene
KAKweku Asare‐Dompreh
Kweku Asare‐Dompreh
WTWilliam Tasiame
William Tasiame
GMGloria Ivy Mensah
Gloria Ivy Mensah
KAKwasi Addo
Kwasi Addo
Q fever is a zoonotic disease caused by Coxiella burnetii, a causative agent of abortion in livestock and febrile illness in humans. Outbreaks of human cases of Q fever have been reported in Australia and the Netherlands, which was linked to abortions in goat and sheep farms. In Ghana, information on Q fever in both livestock and humans is scanty. This study sought to determine the seroprevalence of Q fever in livestock in the Tongu area of the Volta region of Ghana. It was a cross sectional study with blood sampled from 204 cattle, 158 sheep and 100 goats. An indirect ELISA test was performed to detect Q fever antibodies in the serum of livestock. A total of 20 farms were sampled across the municipalities and an overall prevalence of Q fever was 21.6%. Specie‐specific prevalence was 28.4% (45/158) for sheep, 21.7% (45/204) for cattle and 10% (10/100) for goats. Abortions were reported on all the farms sampled and most farmers lived in close proximity to the farms sampled. Q fever is prevalent in the North Tongu area and requires the attention of the veterinary and health authorities, using the One‐ Health approach in order to control its occurrence and save lives.

2 June 2023 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ezekiel vicarezekiel vicar
ezekiel vicar
SASamuel E. K. Acquah
Samuel E. K. Acquah
WWWilliams Walana
Williams Walana
Ezekiel Kofi VicarEzekiel Kofi Vicar
Ezekiel Kofi Vicar
EOEmmanuel K. Osbutey
Emmanuel K. Osbutey
GMGloria Ivy Mensah
Gloria Ivy Mensah
Urinary tract infection (UTI) is frequently encountered during pregnancy and is associated with adverse maternal, fetal, and neonatal effects. However, very little information is available on the prevalence of UTI among pregnant women in the northern part of Ghana, a region with a high birth rate. This study employed a cross-sectional analysis of the prevalence, antimicrobial profile, and risk factors associated with UTI in 560 pregnant women attending primary care for antenatal check-ups. Sociodemographic obstetrical history and personal hygiene information were obtained using a well-structured questionnaire. Afterward, clean catch mid-stream urine samples were collected from all participants and subjected to routine microscopy examination and culture. Of 560 pregnant women, 223 cases (39.8%) were positive for UTI. There was a statistically significant association between sociodemographic, obstetric, and personal hygiene variables and UTI ( ). Escherichia coli (27.8%) was the commonest bacterial isolate followed by CoNS (13.5%) and Proteus species (12.6%). These isolates exhibited greater resistance to ampicillin (70.1–97.3%) and cotrimoxazole (48.1–89.7%) but were fairly susceptible to gentamycin and ciprofloxacin. Gram-negative resistance to meropenem was up to 25.0%, and Gram positives resistance to cefoxitin and vancomycin was up to 33.3% and 71.4% respectively. The current findings extend our knowledge of the high frequency of UTIs and associated risk factors in pregnant women with E. Coli being the predominant and usual isolate. Variation existed in the resistance pattern of isolates to various drugs, underscoring the need to perform urine culture and susceptibility before treatment.

10 September 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
GMGloria Ivy Mensah
Gloria Ivy Mensah
KAKennedy Addo
Kennedy Addo
JTJohn Amissah Tetteh
John Amissah Tetteh
SSSandra Sowah
Sandra Sowah
TLThomas Löscher
Thomas Löscher
DJDolly Jackson-Sillah
Dolly Jackson-Sillah
There has been a long held belief that patients with drug-susceptible TB are non-infectious after two weeks of therapy. Recent microbiological and epidemiological evidence has challenged this dogma, however, the nature of the Mtb-specific cellular immune response during this period has not been adequately investigated. This knowledge could be exploited in the development of immunological biomarkers of early treatment response. Cellular response to four Mtb infection phase-dependent antigens, ESAT-6/CFP-10 fusion protein and three DosR encoded proteins (Rv1733c, Rv2029c, Rv2628) were evaluated in a Ghanaian TB cohort (n=20) before and after 2 weeks of anti TB therapy. After 6-days in vitro stimulation, Peripheral blood mononuclear cell (PBMC) culture supernatant was harvested and the concentration of IFN-γ, Granzyme B, IL-10, IL-17, sIL2Rα and TNF-α were determined in a 6-plex Luminex assay. Frequencies of IFN-γ + CD4 and CD8 T cells were also determined in an intracellular cytokine assay. All antigens induced higher levels of IFN-γ, followed by Granzyme B, TNF-α and IL-17 and low levels of IL-10 and sIL-2R-α in PBMC before treatment and after 2 weeks of treatment. Median cytokine levels of IFN-γ, Granzyme B, IL-17 and sIL-2R-α increased during week two, but it was significant for only Rv1733-specific production of Granzyme B (P = 0. 013). The median frequency of antigen specific IFN-γ + CD4 T cells increased at week two; however, only the increase in the ESAT-6/CFP-10-specific response was significant (P = 0. 0008). In contrast, the median frequency of ESAT-6/CFP-10- specific IFN-γ + CD8 T cell responses declined during week two (P = 0. 0024). Additionally, wide inter-individual variation with three distinct patterns were observed; increase in all cytokine levels, decrease in all cytokine levels and fluctuating cytokine levels after 2 weeks of treatment. The second week of effective chemotherapy was characterized by a general increase in cytokine response to Mtb-specific antigens suggestive of an improvement in cellular response with therapy. However, the wide inter-individual variation observed would limit the utility of cytokine biomarkers during this period.

27 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DJDolly Jackson-Sillah
Dolly Jackson-Sillah
JCJacqueline M. Cliff
Jacqueline M. Cliff
GMGloria Ivy Mensah
Gloria Ivy Mensah
EDEmmanuel Dickson
Emmanuel Dickson
SSSandra Sowah
Sandra Sowah
HDHazel Dockrell
Hazel Dockrell
Early secretory antigenic target 6 (ESAT-6) and culture filtrate protein 10 (CFP-10) are Mycobacterium tuberculosis (Mtb)–specific antigens that are secreted by actively metabolising bacteria and contribute to the virulence of the bacteria. Their ability to induce Treg and Th2 responses, particularly during the first two weeks of treatment, has not been comprehensively examined to date. The purpose of this work was to characterise Th1, Th2 and Treg responses to rESAT-6-CFP10 fusion protein in TB patients before and during the intensive phase of treatment and in healthy M.bovis BCG vaccinated donors. Forty-six newly diagnosed, HIV-negative, smear-positive pulmonary TB patients and 20 healthy donors were recruited in the UK and Ghana. Their peripheral blood mononuclear cells (PBMC) were used in ex vivo ELISPOT and in vitro cultures to identify immunological parameters of interest. The study confirmed that protective immune responses to rESAT-6-CFP10 are impaired in active TB but improved during treatment: circulating antigen-specific IL-4-producing T-cells were increased in untreated TB but declined by two weeks of treatment while the circulating antigen-specific IFN-γ producing T cells which showed a transient rise at one week of treatment, persisted at baseline levels at two months of treatment. In vitro T cell proliferation and IFN-γ production were reduced, while IL-4 and CD4+FoxP3+CD25hi cell expression were increased in response to rESAT-6-CFP10 fusion protein in untreated TB. These responses were reversed during early treatment of TB. These observations support further investigations into the possible utility of these parameters as markers of active disease and favourable treatment outcomes.

2 December 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
KAKennedy Addo
Kennedy Addo
SASamuel Ofori Addo
Samuel Ofori Addo
GMGloria Ivy Mensah
Gloria Ivy Mensah
LMLydia Mosi
Lydia Mosi
FBFrank Adae Bonsu
Frank Adae Bonsu
Mycobacterium tuberculosis complex (MTBC) and Non-tuberculosis Mycobacterium (NTM) infections differ clinically, making rapid identification and drug susceptibility testing (DST) very critical for infection control and drug therapy. This study aims to use World Health Organization (WHO) approved line probe assay (LPA) to differentiate mycobacterial isolates obtained from tuberculosis (TB) prevalence survey in Ghana and to determine their drug resistance patterns. A retrospective study was conducted whereby a total of 361 mycobacterial isolates were differentiated and their drug resistance patterns determined using GenoType Mycobacterium Assays: MTBC and CM/AS for differentiating MTBC and NTM as well MTBDRplus and NTM-DR for DST of MTBC and NTM respectively. Out of 361 isolates, 165 (45.7%) MTBC and 120 (33.2%) NTM (made up of 14 different species) were identified to the species levels whiles 76 (21.1%) could not be completely identified. The MTBC comprised 161 (97.6%) Mycobacterium tuberculosis and 4 (2.4%) Mycobacterium africanum. Isoniazid and rifampicin monoresistant MTBC isolates were 18/165 (10.9%) and 2/165(1.2%) respectively whiles 11/165 (6.7%) were resistant to both drugs. Majority 42/120 (35%) of NTM were M. fortuitum. DST of 28 M. avium complex and 8 M. abscessus complex species revealed that all were susceptible to macrolides (clarithromycin, azithromycin) and aminoglycosides (kanamycin, amikacin, and gentamicin). Our research signifies an important contribution to TB control in terms of knowledge of the types of mycobacterium species circulating and their drug resistance patterns in Ghana.